F-1/A: Cuprina Holdings Files Amendment No. 3 to Form F-1 Registration Statement

Sentiment:

Registration Statement Amendment


Cuprina Holdings (Cayman) Limited files Amendment No. 3 to its Form F-1 registration statement, primarily to include updated exhibits and related updates.

Delay expectedThe company anticipates that its audited financial statements for the fiscal year ended December 31, 2024 will not be available until April 2025, which could delay the IPO.
Capital raiseThe document relates to the registration of Class A Ordinary Shares for a proposed sale to the public, indicating a potential capital raise through an IPO.

Summary

  • Cuprina Holdings (Cayman) Limited has filed Amendment No. 3 to its Form F-1 registration statement with the SEC.
  • The amendment primarily includes the filing of exhibit 23.1 (Consent of Kreit & Chiu CPA LLP) and exhibit 99.7 (Request for Waiver and Representation under Item 8.A.4 of Form 20-F).
  • The company is seeking to register its Class A Ordinary Shares for a proposed sale to the public.
  • The company intends to commence the proposed sale as soon as practicable after the effective date of the registration statement.
  • The company has included audited consolidated financial statements for the fiscal years ended December 31, 2023, 2022 and 2021, and unaudited condensed consolidated interim financial statements for the six month periods ended June 30, 2023 and 2024.
  • The company represents that it is not required by any jurisdiction outside the United States to comply with a requirement to issue audited financial statements not older than 12 months at the date of filing the Registration Statement.
  • The company represents that full compliance with Item 8.A.4 of Form 20-F at present is impracticable and involves undue hardship for the Company.
  • The company does not anticipate that its audited financial statements for the fiscal year ended December 31, 2024 will be available until April 2025.
  • The company will not seek effectiveness of this registration statement on Form F-1 if its audited financial statements are older than 15 months at the time of the company's initial public offering.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The company is progressing with its IPO plans, but there are potential delays related to financial reporting.

Positives

  • The company is moving forward with its IPO plans by filing necessary amendments to its registration statement.
  • The inclusion of audited financial statements for the past three fiscal years provides investors with historical financial data.

Risks

  • The company's audited financial statements for the fiscal year ended December 31, 2024, are not expected to be available until April 2025, which could potentially delay the IPO.
  • The company is relying on a waiver from the SEC regarding the 12-month requirement for financial statements, indicating a potential challenge in meeting standard reporting timelines.

Future Outlook

The company intends to proceed with its IPO as soon as practicable after the registration statement becomes effective, but no earlier than April 2025.

Management Comments

  • David Quek Yong Qi, Director and Chief Executive Officer, signed the registration statement on behalf of Cuprina Holdings (Cayman) Limited.

Industry Context

This announcement reflects Cuprina Holdings' efforts to access public capital markets, a common strategy for companies seeking to fund growth and expansion. The company's agreements with medical and research institutions suggest a focus on the healthcare or biotechnology sectors.

Comparison to Industry Standards

  • The filing of an F-1 registration statement is a standard procedure for companies seeking to list on U.S. stock exchanges.
  • The company's reliance on a waiver for the 12-month financial statement requirement is not uncommon, particularly for foreign private issuers, but it may raise additional scrutiny from investors.

Stakeholder Impact

  • Shareholders: Potential for capital appreciation if the IPO is successful.
  • Employees: Potential for increased job security and opportunities if the company grows.
  • Customers: Potential for improved products and services as the company invests in growth.
  • Suppliers: Potential for increased business as the company expands its operations.

Next Steps

  • The company will need to obtain effectiveness of the registration statement from the SEC.
  • The company will need to finalize the underwriting agreement.
  • The company will need to complete the audit of its 2024 financial statements.
  • The company will then proceed with the pricing and offering of its Class A Ordinary Shares.

Key Dates

DateDescription
May 16, 2022Joint Venture Cum Shareholders Agreement between New Future Medical Services Company and Cuprina Pte. Ltd.
June 3, 2022License Agreement between Nanyang Technological University NTUitive Pte. Ltd. and Cuprina Pte. Ltd.
August 22, 2022Industry Research Collaboration Agreement between Nanyang Technological University and Cuprina Pte. Ltd.
September 22, 2023Issuance of 1 Class A Ordinary Share to Cuprina Holding Pte. Ltd.
January 26, 2023Agreement between Cuprina Pte. Ltd. and Full Crimp Milk LLP
June 1, 2023Exclusive Distribution and Cooperation and Profit-Sharing Agreement between Cuprina Pte. Ltd. and Advanced Biotech and Engineering Limited
January 17, 2024Redesignation of 1 Class B Ordinary Share to Cuprina Holding Pte. Ltd.
January 17, 2024Issuance of Class B Ordinary Shares and Class A Ordinary Shares to various purchasers.
May 15, 2024Date of the report from Kreit & Chiu CPA LLP relating to the consolidated financial statements of Cuprina Holdings (Cayman) Limited.
February 4, 2025Amendment No. 2 to the Registration Statement filed.
February 14, 2025Filing date of Amendment No. 3 to Form F-1 registration statement.

Keywords

Form F-1, registration statement, IPO, Cuprina Holdings, financial statements, SEC, Amendment No. 3, initial public offering

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.